Original Article

Follow-up Study of Medication Errors Reported to the Vaccine Adverse Event Reporting System (VAERS)

Authors: Frederick Varricchio, MD, PHD, John Reed, MD the VAERS Working Group

Abstract

Background: A study was done to determine if the apparent medication errors found in the Vaccine Adverse Event Reporting System (VAERS) database are true errors, and if true errors are found, to determine what corrective action was taken. Furthermore, if a true error did not occur, we wanted to determine at what point the misinformation was entered into the system.


Methods: The VAERS database was searched for reports received between July 1, 2001 and June 30, 2002 which had either been classified as “error” or the word “error” appeared in the text of the report. The database was also searched for reports which indicated that the measles-mumps-rubella (MMR), diphtheria-tetanus-pertussis (DTP), diphtheria-tetanus-acellular pertussis (DTaP) or diphtheria-tetanus-pertussis-haemophilus (DTPH) vaccinations had been administered at an age outside of the usual recommendation.


Results: A total of 119 reports of possible errors were found. Follow-up was successful in 102 (86%) cases. Additional information obtained showed that 26 cases were actual medication errors. Seventy-six cases were not actual medication errors; 9 cases were physician decisions, 37 cases were data entry errors and 30 cases were reporter errors.


Conclusion: The nature of the actual errors was similar to those reported previously; wrong inoculum, improper interval, wrong route of administration, and overdose. Many errors could have been prevented by more attention to detail. Remedial action usually consisted of retraining. The new requirement that all medications be bar-coded, purchasing products from different manufacturers and segregation of vials may help prevent vial confusion.


Key Points


* Errors in vaccine administration occur.


* Most errors could be prevented by more attention to detail.


* System changes may be helpful in preventing errors.


* Information in spontaneous reporting should be verified.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. To Err Is Human: Building a Safer Health System. Washington, DC, National Academy Press, 1999.
 
2. Varricchio F, Iskander J, DeStefano F, et al. Understanding vaccine safety information from the vaccine adverse event reporting system. Pediatr Infect Dis J 2004;23:287–294.
 
3. Baum C, Kweder SL, Anello C. The spontaneous reporting system in the US. In: Strom BL, ed.Pharmacoepidemiology, 2nd ed. New York, New York, Wiley, 1995, pp 125–155.
 
4. Varricchio F. Medication errors submitted to the vaccine adverse event reporting system (VAERS).Vaccine 2002;20:3049–3051.
 
5. Centers for Disease Control and Prevention. Inadvertent intradermal administration of tetanustoxoid-containing vaccines instead of tuberculosis skin tests. MMWR 2004;53:662–664.
 
6. DTaP, Physician’s Desk Reference, 59th ed. Montvale, NJ, Medical Economics Co, 2005, p 756.
 
7. MMR, Physician’s Desk Reference, 59th ed. Montvale, NJ, Medical Economics Co, 2005, p 2075.
 
8. Centers for Disease Control and Prevention. Measles, mumps, and rubella: vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998:47:(No. RR-8).
 
9. Vaccine Adverse Event Reporting System (VAERS) Web site. Available at: http://www.vaers.hhs.gov. Accessed December 5, 2005.
 
10. Varricchio F. The vaccine adverse event reporting system. J Toxicol Clin Toxicol 1998:36:765–768.
 
11. Steinmuller DR. A dangerous error in the dilution of 25 percent albumin. N Engl J Med1998:338:1226–1227.
 
12. Code of Federal Regulations. 21; §201.25; 2004.
 
13. Institute for Safe Medication Practices. Tetanus toxoid vaccines again used for PPD. ISMP Medication Safety Alert 2004:9:16.
 
14. Bates DW, Gawande AA. Improving safety with information technology. N Engl J Med2003;348:2526–2534.
 
15. Varricchio F. Vaccine adverse event reporting: the importance of follow-up. Expert Rev Vaccines2005:4:445–448.